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Abstract 
Cutaneous Squamous Cell Carcinoma (cSCC) is a malignant keratinocyte tumour that develops through the 
suprabasal epidermis. This malignant tumour is the second most common skin malignancy after Basal Cell 
Carcinoma (BCC). The increased incidence of cSCC is directly proportional to increasing age. Generally, the 
predisposing factor of cSCC is exposure to recurrent sunlight for a long time, so localisation of cSCC is a part of 
the body that often exposed to direct sunlight, such as the forehead, face, ears, scalp, neck, and back of the 
hand. The carcinogenesis process of cSCC is a cumulation of a series of events, one of which plays an important 
role is the proliferation index assessed by Ki-67. Forty-eight tissue paraffin blocks were diagnosed 
histopathologically as cutaneous squamous cell carcinoma from the Anatomical Pathology Laboratory of the 
Faculty of Medicine, Universitas Sumatera Utara and the Anatomical Pathology Unit of Haji Adam Malik General 
Hospital Medan, as the research sample. The results of protein expression from Ki-67 were assessed based on 
area. There was no significant correlation between cSCC grading and Ki-67 expression (p > 0.05). Ki-67 antigen 
tumour marker, widely used to determine the level of tumour cell proliferation. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Introduction 
 
Cutaneous Squamous Cell Carcinoma 
(cSCC) is a malignant keratinocyte tumour that 
develops through the suprabasal epidermis [1]. This 
malignant tumour is the second most common skin 
malignancy after Basal Cell Carcinoma (BCC), with an 
amount of 20% of all malignancy in the skin. The 
American Cancer Society noted a comparison 
between cSCC and BCC of 1:3 [2]. It was in line with 
the data on the number of cases at the Polyclinic of 
Department of Dermatology and Venereology at the 
Dr Cipto Mangunkusumo, Central General Hospital, 
Jakarta, who reported the number of cases of BCC as 
many as 261 cases and followed by 69 cases of 
cSCC in 2000-2009. However, epidemiological data 
from the Dharmais Cancer Hospital during 2005-2007 
noted that the most common skin cancer was cSCC 
followed by BCC [3]. The research conducted by Edi 
Kerina at the Haji Adam Malik General Hospital, 
Medan in 2012-2015 also placed cSCC as the most 
common type of skin malignancy above BCC with 59 
cases of cSCC, while the number of BCC cases was 
only 29 cases [4]. The increasing incidence of cSCC 
is directly proportional to increasing age [2]. In 
general, a predisposing factor for cSCC is repeated 
sun exposure over a long period in the older age 
group. People with cSCC with a younger age usually 
have a brown skin colour. The impact of race on the 
incidence of cSCC appears to be at a less frequent 
incidence rate in black groups [5]. 
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Sun exposure predisposes to cSCC, so 
localisation of cSCC is the part of the body most often 
exposed to direct sunlight, such as the forehead, face, 
ears, scalp, neck, and back of the hand. Other 
locations that also often experience malignant 
transformation from keratinocytes are the lower lip 
vermilion [5]. 
The process of carcinogenesis to become 
cutaneous squamous cell carcinoma is the cumulation 
of a series of events in a cell which then undergoes 
malignant transformation. Each stage of the event 
primarily influenced by various factors, both genetic, 
environmental, and food patterns [6]. 
One of a series of events in a cell that plays 
an important role in the carcinogenesis process is a 
cell proliferation index that can be assessed by Ki-67. 
Ki-67 expression is associated with the proliferative 
activity of intrinsic cell populations of malignant 
tumours, thus allowing the use of these markers in 
evaluating tumour aggressiveness [7]. 
This study aims to assess tumour cell 
proliferation in cutaneous squamous cell carcinoma 
through Ki-67 expression. Therefore, the researchers 
were interested in investigating the level of cell 
proliferation (Ki-67 proliferation index) in Squamous 
Cell Carcinoma using histopathological tissue 
preparations obtained from biopsy or excision that 
were fixed with formalin and planted in paraffin blocks. 
 
 
Material and Methods 
 
This study is a descriptive-analytic study with 
a cross-sectional design which aims to assess tumour 
cell proliferation in cutaneous Squamous Cell 
Carcinoma through Ki-67 expression. 
This research was conducted at the 
Anatomical Pathology Laboratory of the Faculty of 
Medicine, Universitas of Sumatera Utara and the 
Anatomical Pathology Unit of Haji Adam Malik 
General Hospital Medan. This research is conducted 
for 16 months, starting from June 2017 to October 
2018, which includes library studies, data collection, 
data processing and writing research reports. 
Samples size in this study were calculated 
based on the sample formula for testing hypotheses in 
one population. Calculations are carried out using a 
confidence level of 95% and 80% power. Based on 
the formula, the samples size of at least 47 was 
found. 
The sample in this study were 48 tissue 
paraffin blocks diagnosed histopathologically as 
cutaneous squamous cell carcinoma that met the 
inclusion criteria. Sampling is done using consecutive 
sampling technique. 
Product data marker Ki-67 antibody biology 
option listed in the core with clone MIB-1; Monoclonal 
antibodies; Dako and dilution of 1:300. Ki-67 are 
proliferating cell nuclear antigen (PCNA) that indirectly 
may reflect the proliferation of tumour cells. Ki-67 
expression assessment using the method 
semiquantitative. 
The percentage of tumor cells at all stained: - 
Score 0 = ≤ 5% positive cells; - Score 1 = 6-25% 
positive cells; - Score 2 = 26-50% positive cells;  - 
Score 3 = 51-75% positive cells; - Score 4 = > 76% 
positive cells.  
We examine the complete clinical data 
needed. Re-reading of all slides from skin tissue was 
diagnosed as cSCC with Hematoxylin Eosin staining 
by two pathologists together with the researcher to 
determine the variance and histology grade. Then the 
serial slides of paraffin blocks were repeated in three 
slides to proceed with each examination with Ki-67 
immunohistochemical staining. 
 
 
Results  
 
The expression of protein from Ki-67 was 
considered broad-based. There was no significant 
correlation between cSCC grading and Ki-67 
expression (p > 0.05) 
Table 1: Correlation Cutaneous Squamous Cell Carcinoma 
Grading with Ki-67 
No Grading 
Ki-67 
P 
Median Mean SD 
1 Well Differentiated 2 33.4 43.1 
0.167 2 Moderately Differentiated 85.5 61.8 42.4 
3 Poorly Differentiated 50 53.8 37.6 
 
 
 
Discussion 
 
Histopathological examination is still the 
primary support in establishing the diagnosis of cSCC 
in addition to holding on to the clinical picture. 
Histopathologically the cSCC found the irregular mass 
of epidermal cells that had proliferated and invaded 
the dermis layer. Cell proliferation rates at cSCC can 
be a consideration in determining cSCC differentiation 
so that it can establish grading from cSCC used to 
develop appropriate prognosis and management. It’s 
also found in a study that states that cells from the 
outer layer of cSCCtumor mass will continue to 
proliferate. In contrast, cells in the layer of tumour 
mass will experience differentiation [8]. 
As a tumour marker, the Ki-67 antigen has 
been widely used to determine the level of 
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proliferation of tumor cells which were most commonly 
used in breast tumors. The Ki-67 antigen encodes two 
isoform proteins with molecular weights 345 and 395 
kDa initially identified by Scholzer and Gerden in the 
early 1980s. This protein appears in all active phases 
of the cell cycle, namely G1, S, G2, and M, but does 
not appear in the G0 phase [9], [10]. Ki-67 is at a low 
level in the G1 and S phases and reaches a peak at 
the beginning of the mitotic phase, but in the next 
phase of mitosis (i.e., during anaphase and 
telophase), there is a decrease in Ki-67 levels. The 
amount of Ki-67 that appears in the cell cycle will be 
governed by the right balance between synthesis and 
degradation which is characterised by a short Ki-67 
half-life, i.e., 1-1.5 hours. The Ki-67 expression is 
associated with the proliferative activity of intrinsic cell 
populations of malignant tumours, thus allowing the 
use of these markers in assessing tumour 
aggressiveness [7]. 
Marinescu et al., (2015) found that the highest 
expression of Ki-67 was found in low differentiated 
cSCC, after conducting p53, p16, and Ki-67 
Immunoexpression studies on cutaneous squamous 
cell carcinoma and precursor lesions [11]. Referring to 
tumour grading currently used than conventionally, 
cSCC is divided subjectively into three histological 
degrees based on nucleus atypia and tumour-formed 
keratinisation [5], namely cSCC well-differentiated, 
cSCC moderately differentiated, and cSCCpoorly 
differentiated, so in this study, the highest Ki-67 
expression was found in cSCC with poor 
differentiation. Accordance with Marinescu et al., 
(2015) who found that the highest Ki-67 expression 
was found cSCC with poorly differentiated [11]. 
In conclusion, the expression of tumour 
marker activity, Ki-67, found no significant correlation 
in establishing cSCC grading. 
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